GLP-1 Receptor Agonist Market Growth, Size, Trends Analysis- By Product, By Application, By Route of Administration, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

GLP-1 Receptor Agonist Market Growth, Size, Trends Analysis- By Product, By Application, By Route of Administration, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

GLP-1 Receptor Agonist Market Introduction and Overview

According to SPER Market Research, ‘Global GLP-1 Receptor Agonist Market Size- By Product, By Application, By Route of Administration, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Global GLP-1 Receptor Agonist Market is estimated to reach USD 266.54 billion by 2033 with a CAGR of 21.9%.

GLP-1 receptor agonists are a type of medication primarily prescribed for managing type 2 diabetes and have recently gained attention for their effectiveness in treating obesity. They function similarly to glucagon-like peptide-1 (GLP-1), a hormone that increases insulin production, delays stomach emptying, decreases glucagon release, and encourages feelings of fullness in response to meals.

The global market for GLP-1 receptor agonists was significantly impacted by the COVID-19 epidemic in a variety of ways. Initially, health care disruption resulted in fewer visits to patients and delayed identification of diabetes and obesity, which in turn led to fewer new prescriptions for these drugs. GLP-1 receptor agonist availability was also impacted by supply chain disruptions, leading to shortages in some areas.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Product, By Application, By Route of Administration, By Distribution Channel
Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered Eli Lilly and Company; Novo Nordisk A/S; AstraZeneca, Sanofi.

GLP-1 Receptor Agonist Market Segmentation:

By Product: Based on the Product, Global GLP-1 Receptor Agonist Market is segmented as; Ozempic,k Trulicity, Mounjaro, Wegovy, Rybelsus, Saxenda, Victoza, Zepbound, Other.

By Route of Administration: Based on the Route of Administration, Global GLP-1 Receptor Agonist Market is segmented as; Parenteral, Oral.

By Distribution Channel: Based on the Distribution Channel, Global GLP-1 Receptor Agonist Market is segmented as; Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

By Region: This research also include data for North America, Europe, Asia-Pacific Middle East & Africa and South America.